...
首页> 外文期刊>Regulatory peptides. >Receptor mechanisms of bradykinin-mediated activation of prenodal lymphatic smooth muscle.
【24h】

Receptor mechanisms of bradykinin-mediated activation of prenodal lymphatic smooth muscle.

机译:缓激肽介导的结节前淋巴平滑肌活化的受体机制。

获取原文
获取原文并翻译 | 示例

摘要

We have previously shown that several endogenous vasoactive agents constrict prenodal lymph vessels in the canine forelimb. In this study, we assessed the receptor mechanisms by which bradykinin activates lymphatic smooth muscle. Intralymphatic (i.l.) infusion of bradykinin at concentrations of 3.82 x 10(-6), 3.82 x 10(-5) and 3.82 x 10(-4) molar significantly increased lymphatic perfusion pressure. To determine the potential role of lymphatic alpha-receptors in this response, we infused bradykinin at a concentration of 3.82 x 10(-4) molar i.l. before and during intra-arterial (i.a.) phentolamine administration. Prior to phentolamine, bradykinin resulted in a doubling of the lymphatic perfusion pressure. Phentolamine alone had no effect on the resting lymphatic pressure, but significantly reduced forelimb arterial pressures. When the infusion of bradykinin was repeated during phentolamine administration, there was no significant change in the lymphatic perfusion pressure. To determine the subclass of alpha-adrenergic receptors involved in this response, we infused bradykinin and the alpha1-receptor agonist phenylephrine i.l. before and during administration of i.a. prazosin, a specific alpha1-receptor antagonist, i.a. Prior to prazosin, both phenylephrine and bradykinin significantly increased lymphatic perfusion pressure. During prazosin administration, neither phenylephrine nor bradykinin significantly altered the lymphatic perfusion pressure. These data indicate that bradykinin-mediated increases in prenodal lymphatic smooth muscle tone are mediated by lymphatic alpha1-adrenergic receptors.
机译:先前我们已经表明,几种内源性血管活性剂会收缩犬前肢中的结节前淋巴管。在这项研究中,我们评估了缓激肽激活淋巴平滑肌的受体机制。以3.82 x 10(-6),3.82 x 10(-5)和3.82 x 10(-4)摩尔的浓度向淋巴内(i。)注入缓激肽可显着增加淋巴灌注压力。为了确定淋巴α受体在这种反应中的潜在作用,我们以3.82 x 10(-4)摩尔i.l的浓度注入缓激肽。在动脉内(i.a.)酚妥拉明给药之前和期间在酚妥拉明之前,缓激肽导致淋巴灌注压力加倍。单独的酚妥拉明对静息的淋巴压没有影响,但是会显着降低前肢的动脉压。在苯妥拉明给药期间重复输注缓激肽时,淋巴灌注压力无明显变化。为了确定参与该反应的α-肾上腺素受体的亚类,我们注入缓激肽和α1-受体激动剂去氧肾上腺素i.l。在i.a.的管理之前和期间哌唑嗪,一种特定的α1-受体拮抗剂,即在哌唑嗪之前,去氧肾上腺素和缓激肽都显着增加淋巴灌注压力。在哌唑嗪给药期间,去氧肾上腺素和缓激肽均未显着改变淋巴灌注压力。这些数据表明,缓激肽介导的结节前淋巴平滑肌音调的增加是由淋巴性α1-肾上腺素能受体介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号